Nomogram for predicting bleeding events in nonvalvular atrial fibrillation patients receiving rivaroxaban: A retrospective study.
Chang CaoYijiao XuWeiwen JiangShujing WuYun ShenXiaotong XiaLumin WangHuijun ZhangHongni JiangXiaoyu LiXiaoye LiYan-Rong YePublished in: Health science reports (2024)
PT in combination with CHA2DS2-VASc and HASBLED could be considered as a more practical and accurate method for predicting bleeding events in patients taking rivaroxaban.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- catheter ablation
- left atrial appendage
- left atrial
- direct oral anticoagulants
- heart failure
- end stage renal disease
- ejection fraction
- percutaneous coronary intervention
- newly diagnosed
- venous thromboembolism
- chronic kidney disease
- prognostic factors
- patient reported outcomes
- squamous cell carcinoma
- coronary artery disease
- left ventricular
- patient reported